SOD2 and ovarian carcinoma: In fact, a study performed in ovarian cancer cells subjected to paclitaxel treatment, which increases ROS levels, reported that FOXO1 upregulated the cells’ oxidative stress resistance by inducing the expression of manganese superoxide dismutase (MnSOD) [67].